ArticleFrontiers in oncology2025

HER2 inhibitor-based combination therapy for recurrent and metastatic salivary duct carcinoma in an elderly patient: a case report and literature review.

Luxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.